Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | AZN | AMGN | GILD | BMY |
| Company | Roivant Sciences Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 29.20 | 194.01 | 364.20 | 143.56 | 60.43 |
| High | 29.38 | 194.83 | 369.76 | 144.65 | 60.43 |
| Low | 28.31 | 192.76 | 361.70 | 142.77 | 59.45 |
| Latest | 28.78 | 194.22 | 369.53 | 143.93 | 60.29 |
| Change | -0.94 | -3.30 | +1.93 | -1.21 | -0.45 |
| % Change | -3.16% | -1.67% | +0.53% | -0.83% | -0.74% |
| Volume | 5,686,400 | 1,473,800 | 2,443,000 | 4,921,300 | 11,401,900 |
| 20-Day Average Volume | 7,493,760 | 2,340,165 | 2,746,930 | 7,638,000 | 13,281,535 |
| Previous Close | 29.72 | 197.52 | 367.60 | 145.14 | 60.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.81 | 202.44 | 376.17 | 149.85 | 60.99 |
| 20-Day Raw Stochastic | 79.36% | 27.91% | 28.16% | 7.99% | 28.99% |
| 20-Day Relative Strength | 63.97 | 48.14 | 53.69 | 51.63 | 55.96 |
| Weighted Alpha | +197.29 | +30.96 | +22.79 | +30.66 | +12.15 |
| Today's Opinion | 100% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 64% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.55% since 02/27/26 | -6.83% since 02/27/26 | -4.80% since 02/27/26 | -3.37% since 02/27/26 | -3.33% since 02/27/26 |
| Low | 26.94 on 03/03/26 | 192.76 on 03/06/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.44 on 03/06/26 |
| High | 30.03 on 03/05/26 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +11.46% since 02/06/26 | +0.62% since 02/06/26 | -3.85% since 02/06/26 | -5.62% since 02/06/26 | -2.74% since 02/06/26 |
| Low | 25.72 on 02/09/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 30.03 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +37.24% since 12/05/25 | +7.68% since 12/05/25 | +12.02% since 12/05/25 | +18.73% since 12/05/25 | +15.61% since 12/05/25 |
| Low | 20.14 on 12/10/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 30.03 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +122.76% since 09/05/25 | +18.86% since 09/05/25 | +30.28% since 09/05/25 | +25.10% since 09/05/25 | +27.90% since 09/05/25 |
| Low | 12.55 on 09/08/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 30.03 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,597,876 | 301,217,344 | 199,201,792 | 178,677,728 | 122,779,024 |
| Shares Outstanding, K | 715,701 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 29,050,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -171,980,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 2,000,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -265,890,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.17 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 02/06/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 06/04/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.56 | 16.82 | 17.81 | 9.88 |